dc.contributor.author | Kalpaklioglu, AF | |
dc.contributor.author | Kara, T | |
dc.contributor.author | Kurtipek, E | |
dc.contributor.author | Kocyigit, P | |
dc.contributor.author | Ekici, A | |
dc.contributor.author | Ekici, M | |
dc.date.accessioned | 2020-06-25T17:40:38Z | |
dc.date.available | 2020-06-25T17:40:38Z | |
dc.date.issued | 2005 | |
dc.identifier.issn | 1081-1206 | |
dc.identifier.issn | 1534-4436 | |
dc.identifier.uri | https://doi.org/10.1016/S1081-1206(10)61137-4 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12587/3506 | |
dc.description | Ekici, Arif B/0000-0001-6099-7066 | en_US |
dc.description | WOS: 000229400900014 | en_US |
dc.description | PubMed: 15945562 | en_US |
dc.description.abstract | Background: Chronic cough is a common condition that has a significant impact on health-related quality of life (HRQoL). Objective: To investigate whether chronic cough is associated with adverse psychological and physical effects on quality of life (QoL) using different HRQoL questionnaires. Methods: Forty patients were recruited for the study. The diagnostic workup was mainly based on the pathogenic triad in chronic cough: postnasal drip syndrome, asthma, and gastroesophageal reflux disease. The HRQoL was evaluated with the cough-specific quality-of-life questionnaire (CQLQ), Leicester Cough Questionnaire (LCQ), Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36), and Hospital Anxiety and Depression Scale. Results: Symptom scores were significantly correlated with the CQLQ and LCQ (beta =.415 and beta = -.272, respectively) but not with the SF-36. A statistically significant difference was found in all questionnaires, except the physical component summary domain of the SF-36, after specific therapy. Correlation between the 2 specific HRQoL questionnaires was moderate to high when pretreatment and posttreatment scores were compared (r = -0.42 and r = -0.60). Concurrent validity of the LCQ was higher than the CQLQ when compared with the SF-36 domains. The effect size of each specific QoL questionnaire was I or higher after treatment, whereas it was much less in the SF-36. There was no change in depression with treatment despite anxiety. Posttreatment symptom scores were related with anxiety (r > 0.40) Conclusions: Because HRQoL is important to patients, a cough-specific HRQoL instrument, either the CQLQ or LCQ, should be routinely used to optimally evaluate the impact of cough on patients and to evaluate the efficacy of cough-modifying agents. Ann Allergy Asthma Immunol. 2005;94:581-585. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Elsevier Science Inc | en_US |
dc.relation.isversionof | 10.1016/S1081-1206(10)61137-4 | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Evaluation and impact of chronic cough: comparison of specific vs generic quality-of-life questionnaires | en_US |
dc.type | article | en_US |
dc.contributor.department | Kırıkkale Üniversitesi | en_US |
dc.identifier.volume | 94 | en_US |
dc.identifier.issue | 5 | en_US |
dc.identifier.startpage | 581 | en_US |
dc.identifier.endpage | 585 | en_US |
dc.relation.journal | Annals Of Allergy Asthma & Immunology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |